Management Credibility Analysis

Unavailable
Verified Management Score Unavailable
Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed
Verified Catalysts Unavailable
No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive
Not disclosed
Headquarters
INDUSTRIEPARK ZWIJNAARDE 7, ZWIJNAARDE, C9
Founded
Not disclosed

📈 Company Timeline

Major business events
Positive
Negative
Neutral
27 Aug 2026

argenx SE tender offer filing

argenx SE filed Schedule TO-T/A (amended third-party tender offer).

19 Aug 2026

argenx SE tender offer filing

argenx SE filed Schedule TO-T/A (amended third-party tender offer).

14 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in argenx SE.

6 Aug 2026

argenx SE tender offer filing

argenx SE filed Schedule TO-T/A (amended third-party tender offer).

6 Aug 2026

argenx SE tender offer filing

argenx SE filed Schedule TO-T (third-party tender offer).

Capital Structure & Financial Position

Financial strength and liquidity analysis
Verified Capital Structure Unavailable
Balance-sheet, credit-rating, debt, and capital-activity data require sourced financial statement ingestion.

Peer Comparison - Health Care

Company Price Market Cap
LLY - Eli Lilly and Company $1,276.13
Yahoo Finance 		$1.20T
JNJ - Johnson & Johnson $256.74
Yahoo Finance 		$618.71B
ABBV - AbbVie Inc. $284.80
Yahoo Finance 		$503.28B
UNH - UnitedHealth Group Incorporated $418.43
Yahoo Finance 		$375.58B
MRK - Merck & Co., Inc. $148.55
Yahoo Finance 		$366.50B

📋 Corporate Actions

Recent and upcoming corporate events
Verified Corporate Actions Unavailable
Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis
Verified Financial Statements Unavailable
Verified financial statement data is not ingested for this stock yet.

Analyst Consensus

Buy
Target: $1,163.00
32.7% upside potential
📈
Strong Buy
Unavailable
👍
Buy
19
⏸️
Hold
1
📉
Sell
0
20 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved Targets range 823.00–1,400.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments
Verified Dividend Data Unavailable
Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable
Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity
Verified Insider Transactions Unavailable
Director and insider transaction data is not ingested for this stock yet.

Top Shareholders

Fmr Llc
5,231,452 shares
4.817% change
6/30/2026
Price T Rowe Associates Inc /Md/
2,678,047 shares
-20.649% change
6/30/2026
Janus Henderson Group Ltd.
2,541,732 shares
3.4% change
3/31/2026
Jupiter Topco Llc
2,474,015 shares
New% change
6/30/2026
Capital World Investors
2,199,770 shares
-2.502% change
6/30/2026
Artisan Partners Limited Partnership
1,508,778 shares
2.779% change
6/30/2026
Avoro Capital Advisors Llc
1,000,000 shares
0% change
6/30/2026
Wellington Management Group Llp
930,548 shares
-8.9% change
6/30/2026
Blackrock, Inc.
777,237 shares
-3.847% change
6/30/2026
Rtw Investments, Lp
709,446 shares
0% change
6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed · 1 day ago